Open access
Open access
Powered by Google Translator Translator

Internal Medicine

Video: Why you can’t compare Covid-19 vaccines

2 Apr, 2021 | 09:33h | UTC

Why you can’t compare Covid-19 vaccines – Vox

 


Long Covid in the UK – More than a million affected in February, survey suggests

2 Apr, 2021 | 09:31h | UTC

Long Covid: More than a million affected in February, survey suggests – BBC

Report: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 1 April 2021 – Office for National Statistics

 

Commentary on Twitter

 


Why is it so hard to investigate the rare side effects of COVID vaccines?

2 Apr, 2021 | 09:28h | UTC

Why is it so hard to investigate the rare side effects of COVID vaccines? – Nature

 


[Press release – not published yet] Pfizer/BioNTech vaccine is 91% effective for at least 6 months

2 Apr, 2021 | 09:29h | UTC

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study

Commentaries: Ongoing trial shows Pfizer Covid-19 vaccine remains highly effective after six months – CNN AND Coronavirus: Pfizer jab ‘stopping 91% of cases in first six months’ – BBC AND Expert reaction to press release from Pfizer and BioNTech on efficacy and safety up to six months after second vaccine dose, including data from South Africa – Science Media Centre AND Pfizer’s COVID-19 vaccine effective after 6 months and works against problem variant – LiveScience

 


Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis

2 Apr, 2021 | 09:23h | UTC

Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis – The Lancet Global Health

Commentaries: Covid-19 led to a global increase in stillbirths, maternal mortality, and depression, review finds – CNN AND COVID-19 pandemic and health-care disruptions: count the most vulnerable – The Lancet Global Health

 

Commentary on Twitter

 


Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19

2 Apr, 2021 | 09:36h | UTC

Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2 – Nature Medicine

Commentary: If I’ve Had COVID-19, Do I Still Need Two Doses of Vaccine? – TIME AND The research is in: People who’ve already had COVID-19 need just one shot – Insider

Related: Studies: Single dose of vaccine acts as ‘booster’ in those with prior COVID-19 infection (studies and commentary) AND Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2 – JAMA AND Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine – New England Journal of Medicine

 


Rapid point-of-care tests for diagnosing COVID-19 infection: the latest Cochrane evidence

2 Apr, 2021 | 09:21h | UTC

Rapid point-of-care tests for diagnosing COVID-19 infection: the latest Cochrane evidence – Evidently Cochrane

Original review and commentaries: Systematic review: Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection

 


Therapeutics and COVID-19 | WHO guideline update advises Ivermectin should only be used to treat COVID-19 within clinical trials

1 Apr, 2021 | 04:02h | UTC

Summary and Infographic: Drug treatments for covid-19: living systematic review and network meta-analysis – The BMJ

Original guideline: Therapeutics and COVID-19: living guideline – World Health Organization

News release: WHO advises that ivermectin only be used to treat COVID-19 within clinical trials – World Health Organization

Commentary: WHO joins Europe, Merck in recommending against ivermectin for COVID-19 – Reuters

 

Commentary on Twitter

https://twitter.com/ThomasAgoritsas/status/1377372928451301384

 


Consensus Document: Management of superficial and deep surgical site infection

1 Apr, 2021 | 03:33h | UTC

Management of superficial and deep surgical site infection: an international multidisciplinary consensus – Updates in Surgery

Related Guidelines: Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017 – JAMA Surgery AND Global guidelines on the prevention of surgical site infection – World Health Organization AND Surgical site infections: prevention and treatment – National Institute for Health and Care Excellence AND APSIC guidelines for the prevention of surgical site infections – Antimicrobial Resistance & Infection Control

 


M-A: Vitamin D supplementation to prevent acute respiratory infections

1 Apr, 2021 | 03:30h | UTC

Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials – The Lancet Diabetes & Endocrinology

Commentaries: Vitamin D to prevent acute respiratory infections – The Lancet Diabetes & Endocrinology AND

 


RCT: Reduced-sodium added-potassium salt substitute reduces blood pressure in hypertensive patients

1 Apr, 2021 | 03:32h | UTC

Effects of a reduced-sodium added-potassium salt substitute on blood pressure in rural Indian hypertensive patients: a randomized, double-blind, controlled trial – American Journal of Clinical Nutrition

Commentary: Salt substitution — an effective way to reduce blood pressure in rural India – The George Institute for Global Health

 

Commentaries on Twitter

https://twitter.com/Dr_WuJ/status/1376715405553590275

 


Cohort study: Association of spontaneous abortion with all cause and cause specific premature mortality

1 Apr, 2021 | 03:27h | UTC

Association of spontaneous abortion with all cause and cause specific premature mortality: prospective cohort study – The BMJ

Commentaries: Miscarriage linked to increased risk of early death – The BMJ AND Miscarriage Linked to Higher Risk for Premature Mortality – HealthDay

 

Commentary on Twitter

 


Editorial | Vaccine certificates: does the end justify the means?

1 Apr, 2021 | 03:41h | UTC

Vaccine certificates: does the end justify the means? – The Lancet Microbe

Related: Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion AND Covid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion AND “Vaccine Passport” Certification — Policy and Ethical Considerations – New England Journal of Medicine AND Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers – World Health Organization

 


WHO: Sinopharm, Sinovac COVID-19 vaccine data show efficacy

1 Apr, 2021 | 03:58h | UTC

Sinopharm, Sinovac COVID-19 vaccine data show efficacy: WHO – Reuters

 

Commentary on Twitter

https://twitter.com/hildabast/status/1377377034180038659

 


AstraZeneca COVID vaccine 70% effective vs. B117 variant

1 Apr, 2021 | 03:55h | UTC

AstraZeneca COVID vaccine 70% effective vs B117 variant – CIDRAP

Original study: Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial – The Lancet

 

Commentary on Twitter (thread – Click for more)

 


Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study

1 Apr, 2021 | 03:43h | UTC

Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study – The BMJ

 

Commentary on Twitter

 


Opinion | “Vaccine Passport” Certification — Policy and Ethical Considerations

1 Apr, 2021 | 03:40h | UTC

“Vaccine Passport” Certification — Policy and Ethical Considerations – New England Journal of Medicine

Related: Covid-19 vaccine passports will harm sustainable development – The BMJ Opinion AND Covid-19 vaccine passports and vaccine hesitancy: freedom or control? – The BMJ Opinion AND Vaccine certificates: does the end justify the means? – The Lancet Microbe AND Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers – World Health Organization

 


M-A: Efficacy and safety of low-dose colchicine in patients with coronary disease

31 Mar, 2021 | 03:11h | UTC

Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials – European Heart Journal (link to abstract – $ for full-text)

 


Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries

31 Mar, 2021 | 03:10h | UTC

Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries – British Journal of Sports Medicine

Commentaries: Physical inactivity is responsible for up to 8% of non-communicable diseases and deaths worldwide – British Medical Journal AND ‘Couch Potato’ Lifestyles Cause Up to 8% of Global Deaths: Study – HealthDay

 

Commentary on Twitter

 


Review and Algorithm: Tuberculosis and the Heart

31 Mar, 2021 | 03:07h | UTC

Tuberculosis and the Heart – Journal of the American Heart Association

 

Commentary on Twitter

 


Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature

31 Mar, 2021 | 03:01h | UTC

Diagnosis and clinical management of hepatosplenic schistosomiasis: A scoping review of the literature – PLOS Neglected Tropical Diseases

 


Antibody evasion by the P.1 strain of SARS-CoV-2

31 Mar, 2021 | 03:36h | UTC

Antibody evasion by the P.1 strain of SARS-CoV-2 – Cell

 

Commentary on Twitter (thread – Click for more)

 


Why indoor spaces are still prime COVID hotspots

31 Mar, 2021 | 03:35h | UTC

Why indoor spaces are still prime COVID hotspots – Nature

 


[Preprint] Single dose of AstraZeneca and Pfizer vaccines shows 62% efficacy for preventing disease and reduces viral load/transmissibility of SARS-CoV-2 in residents of Long-Term Care Facilities

31 Mar, 2021 | 03:38h | UTC

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of Long-Term Care Facilities (VIVALDI study) – medRxiv

Commentaries: Single dose of Pfizer and Oxford vaccines shows 60% efficacy in elderly care home residents – NewsMedical AND Care home residents gain 62% protection from single dose of COVID-19 vaccine – University College London

 

Commentary on Twitter (thread – click for more)

https://twitter.com/sailorrooscout/status/1376512132318121990

 


Transmissibility and transmission of respiratory viruses

31 Mar, 2021 | 03:33h | UTC

Transmissibility and transmission of respiratory viruses – Nature Reviews Microbiology

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.